Latest Breaking News On - Joseph oliveto - Page 4 : comparemela.com

Milestone Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Corporate Update

- NDA submission for etripamil in patients with PSVT currently on track for 3Q23 - Company to host virtual KOL event focused on etripamil for the potential treatment of AFib-RVR on. | May 11, 2023

United statesJoseph olivetoSethhz fischerDavid pittsVivus incExchange commissionProgram updatesSpectrum pharmaceuticals incMilestone pharmaceuticalsCordis corporationSociety for health economicsCenters for diseaseCompany board of directorsUs securities exchange commissionAgile therapeutics incMilestone pharmaceuticals inc

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Corporate Update

/PRNewswire/ Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative.

United statesDavid pittsJoseph olivetoSeth fischerSethhz fischerVivus incExchange commissionProgram updatesUs securities exchange commissionMilestone pharmaceuticals incSpectrum pharmaceuticals incCompany board of directorsCordis corporationMarinus pharmaceuticals incAmerican heart associationAgile therapeutics inc

Form 10-K Milestone Pharmaceutical For: Dec 31

Form 10-K Milestone Pharmaceutical For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJi xingVille saint laurentUnited kingdomRepublic of chinaTaiwan generalNew zealandSouth africaNorth carolinaHong kongDistrict of columbiaSouth koreaDebrak liebertLorenz mullerDavid bharuchaMichael tomsicek

Milestone Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Corporate Update

Milestone Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJi xingJoseph olivetoMilestone pharmaceuticals incUs securities exchange commissionMontreal heart instituteCenters for diseaseAmerican heart associationJi xing pharmaceuticalsDrug administrationJi xing pharmaceuticals limitedPrnewswire milestone pharmaceuticals incExchange commissionMilestone pharmaceuticalsChief executive officerNew drug application

Milestone Pharmaceuticals Announces New Data from Phase 3 RAPID Trial of Etripamil Nasal Spray in Patients with PSVT During Late-Breaking Session at the AHA Scientific Sessions 2022

Trial met its primary endpoint, with 64.3% of patients receiving etripamil converting to sinus rhythm within 30 minutes compared to 31.2% on placebo (HR =.

United statesKaplan meierJames ipDavid pittsJoseph olivetoMilestone pharmaceuticals incUs securities exchange commissionAmerican heart associationDrug administrationDivision of cardiologyPrnewswire milestone pharmaceuticals incExchange commissionMilestone pharmaceuticalsPrimary analysisLate breaking clinical trialsScientific sessions